Vyvanse Cost in New Jersey: 2026 Prices, Insurance, and Savings Options

Prescription access and medication affordability image for Vyvanse Cost in New Jersey: 2026 Prices, Insurance, and Savings Options

At a glance

  • Takeda list price / $390 per month (30 capsules)
  • Average NJ cash-pay price / approximately $35 per month with discount card
  • NJ Medicaid status / covered with prior authorization
  • Compounded lisdexamfetamine / available via licensed 503A pharmacies in NJ
  • Telehealth prescribing / permitted in New Jersey
  • Dose form / oral capsule, taken once in the morning
  • FDA-approved indications / ADHD (ages 6+) and moderate-to-severe binge eating disorder in adults
  • Generic lisdexamfetamine / available since August 2023 from multiple manufacturers
  • Takeda savings card / eligible commercially insured patients may pay as little as $30 per month
  • DEA schedule / Schedule II controlled substance

What Does Vyvanse Actually Cost in New Jersey in 2026?

The price you pay for Vyvanse (lisdexamfetamine dimesylate) in New Jersey depends almost entirely on how you fill your prescription. Takeda Pharmaceutical still lists the brand at $390 per month for a 30-count supply of any strength from 10 mg to 70 mg [1]. That number rarely reflects what patients hand over at the counter.

Since generic lisdexamfetamine entered the U.S. market in August 2023, cash-pay prices have dropped steeply. NJ retail pharmacies in 2026 average approximately $35 per month when patients use a pharmacy discount card or coupon aggregator. Without any discount, generic cash prices at independent NJ pharmacies range from about $30 to $80 depending on dose strength and location. Brand Vyvanse without insurance or a coupon can still exceed $350 at some chain pharmacies in Bergen, Essex, and Middlesex counties.

The Vyvanse FDA-approved label lists six capsule strengths (10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg), all priced identically by Takeda [2]. This flat pricing means dose titration does not change your monthly bill. A 2017 analysis by Wigal and colleagues in the Journal of Attention Disorders confirmed that lisdexamfetamine's efficacy across its dose range supports individualized titration without cost-driven dose compromises [3].

Patients filling at Costco, CostPlus Drugs, or Amazon Pharmacy locations in New Jersey often report the lowest generic prices, sometimes below $20 per month for the 30 mg capsule.

How New Jersey Medicaid Covers Vyvanse

New Jersey Medicaid (NJ FamilyCare) does cover Vyvanse, but you will need prior authorization before the state will pay for it. The PA requirement exists because Medicaid preferred drug lists (PDLs) typically favor generic amphetamine mixed salts or methylphenidate formulations as first-line agents.

To obtain PA approval in NJ, your prescriber generally must document that a first-line stimulant was tried and failed or was clinically inappropriate. The American Academy of Pediatrics (AAP) 2019 clinical practice guideline recommends stimulant medications as first-line pharmacotherapy for ADHD in children aged 6 and older [4]. Lisdexamfetamine fits within that recommendation, but Medicaid formularies require the step-therapy documentation before covering it.

NJ FamilyCare covers both children and adults with ADHD diagnoses. For binge eating disorder (BED), the second FDA-approved indication, the PA pathway may differ and often requires documentation of a BED-specific assessment. The FDA approved Vyvanse for moderate-to-severe BED in adults in January 2015, based on two key trials (Studies 331-303 and 331-304) that demonstrated a statistically significant reduction in binge eating days per week versus placebo (P<0.001) [2].

If your PA is denied, New Jersey Medicaid allows a formal appeal. The turnaround for standard PA decisions is typically 24 to 72 hours for outpatient prescriptions.

Generic Lisdexamfetamine vs. Brand Vyvanse in NJ

Generic lisdexamfetamine capsules became available in August 2023 after Takeda's settlement agreements with several generic manufacturers took effect. The FDA requires generics to demonstrate bioequivalence to the reference listed drug, meaning they must deliver the same active ingredient at the same rate and extent of absorption [5].

The price gap is significant. Brand Vyvanse at a New Jersey CVS or Walgreens runs $350 to $400 without insurance. Generic lisdexamfetamine at the same pharmacy runs $30 to $60 with a discount card. That difference alone saves NJ patients roughly $3,600 to $4,200 per year.

Some patients and clinicians have raised questions about whether generic stimulants perform identically to their branded counterparts. The FDA's bioequivalence standard requires the 90% confidence interval for the generic's AUC and Cmax to fall within 80% to 125% of the brand [5]. Real-world data have not shown clinically meaningful differences for lisdexamfetamine generics specifically, though individual responses can vary.

"Patients switching from brand to generic lisdexamfetamine should be monitored at their next follow-up visit, but most tolerate the transition without dose adjustment," notes guidance from the American Academy of Child and Adolescent Psychiatry (AACAP) [6].

Is Compounded Lisdexamfetamine Legal in New Jersey?

Yes. Compounded lisdexamfetamine is available through licensed 503A compounding pharmacies in New Jersey. A 503A pharmacy compounds medications pursuant to a valid, patient-specific prescription under section 503A of the Federal Food, Drug, and Cosmetic Act [7].

There are limits. A 503A pharmacy cannot compound copies of commercially available drugs unless the prescriber documents a clinical need for the compounded version (for example, a patient who cannot swallow capsules and needs an oral solution at a non-standard concentration). The compounder must use bulk drug substances that meet USP or NF standards.

Compounded lisdexamfetamine can cost significantly less than brand Vyvanse. Some NJ 503A pharmacies offer compounded oral solutions for under $50 per month. Pricing varies by pharmacy and preparation.

Because lisdexamfetamine is a Schedule II controlled substance under the DEA, NJ compounding pharmacies must hold both a state Board of Pharmacy license and a DEA registration to compound it. Patients should verify that any pharmacy offering compounded lisdexamfetamine displays both credentials.

New Jersey does not have a state-level ban on compounding Schedule II stimulants, unlike a small number of states that impose additional restrictions.

Insurance Coverage for Vyvanse Across NJ Plans

Most commercial insurance plans sold in New Jersey cover Vyvanse or generic lisdexamfetamine, but formulary tier placement varies widely. Here is what NJ residents typically encounter across major insurer types.

Employer-sponsored plans: Lisdexamfetamine generics usually sit on Tier 2 (preferred brand) or Tier 3 (non-preferred) formularies. Copays range from $10 to $50 per month. Brand Vyvanse, if covered at all, often requires a higher copay or step therapy through a generic first.

ACA Marketplace plans (NJ Get Covered NJ): Plans must cover at least one drug per therapeutic class. ADHD stimulants are included. Generic lisdexamfetamine is increasingly the default covered product, with brand Vyvanse available through exceptions.

Medicare Part D: Stimulants were excluded from Part D coverage for years, but the Medicare Improvements for Patients and Providers Act did not extend mandatory coverage to ADHD medications for adults on Medicare. Some Medicare Advantage plans offer supplemental coverage. Patients 65 and older in NJ should check their specific plan formulary.

NJ Medicaid (NJ FamilyCare): Covered with PA, as described above.

The 2023 IQVIA National Prescription Audit reported that lisdexamfetamine was the third most-dispensed branded ADHD medication in the United States before generics entered, with over 16.4 million prescriptions filled in 2022 [8]. Generic entry has shifted that volume substantially.

The Takeda Vyvanse Savings Card: How It Works in NJ

Takeda offers a manufacturer savings card (sometimes called a copay card) for brand-name Vyvanse. Eligible patients with commercial insurance can reduce their out-of-pocket cost to as low as $30 per 30-day fill [1].

Key eligibility rules for NJ residents:

  • You must have commercial (private) insurance. Patients on Medicaid, Medicare, TRICARE, or other government-funded programs are not eligible.
  • The card covers up to a maximum annual benefit (typically $60 per fill, capped at $720 per year, though terms change periodically).
  • The card is accepted at virtually all NJ retail pharmacies that process commercial claims electronically.

Patients without any insurance cannot use the Takeda savings card. For uninsured NJ residents, Takeda also operates the Help at Hand Patient Assistance Program, which provides brand Vyvanse at no cost to qualifying individuals with household income at or below 250% of the federal poverty level [1].

"Manufacturer copay assistance programs can meaningfully reduce treatment discontinuation for branded ADHD medications," according to a 2021 analysis published in the Journal of Managed Care & Specialty Pharmacy [9].

Getting Vyvanse via Telehealth in New Jersey

New Jersey permits telehealth prescribing of Vyvanse and other Schedule II controlled substances. The state adopted permanent telehealth parity legislation (S.B. 2559) in 2020, which allows initial and follow-up prescribing via synchronous audio-video visits [10].

There are federal requirements too. The DEA's telemedicine prescribing rules, updated in late 2024 and extended through 2025, allow practitioners to prescribe Schedule II controlled substances via telehealth if they conduct a live, real-time video evaluation and comply with state-specific requirements [11].

Several telehealth platforms operating in NJ (including Done, Cerebral, and Ahead) prescribe lisdexamfetamine after a diagnostic evaluation. Appointment costs range from $150 to $300 for an initial visit, with follow-ups typically $85 to $150. The prescription itself is sent electronically to the patient's preferred NJ pharmacy. Paper prescriptions are not permitted for Schedule II substances in New Jersey.

NJ telehealth visits for controlled substances must be conducted by a prescriber licensed in the state of New Jersey. Out-of-state prescribers cannot prescribe Schedule II medications to NJ residents unless they hold a valid NJ medical license and NJ CDS registration.

Practical Tips to Lower Your Vyvanse Cost in NJ

Getting the lowest possible price requires a few deliberate steps. The approach differs based on your insurance situation.

If you have commercial insurance: Ask your prescriber to submit a prior authorization for lisdexamfetamine generic if the plan requires one. Use the Takeda savings card for brand Vyvanse if your plan's copay exceeds $30. Check whether your plan's mail-order pharmacy offers a 90-day supply discount.

If you are uninsured: Fill the generic at a discount pharmacy. Costco does not require membership to use its pharmacy in New Jersey. Compare prices across at least three NJ pharmacies using GoodRx or RxSaver before filling.

If you are on NJ Medicaid: Work with your prescriber to complete the PA paperwork. If denied, request the specific denial reason and appeal with supporting clinical documentation. The NJ Division of Medical Assistance and Health Services processes appeals within 20 business days.

If you want compounded lisdexamfetamine: Ask your prescriber whether a compounded oral solution is clinically appropriate. Locate a 503A-licensed pharmacy in NJ through the state Board of Pharmacy's online verification tool.

Wigal et al. demonstrated in their 2017 study that lisdexamfetamine's prodrug design provides consistent plasma levels across its dosing range, which supports once-daily dosing and reduces the need for midday redosing common with immediate-release amphetamines [3]. That once-daily fill also means one copay per month rather than split prescriptions.

Frequently asked questions

How much does Vyvanse cost in New Jersey?
Brand Vyvanse lists at $390 per month. Generic lisdexamfetamine averages about $35 per month at NJ retail pharmacies with a discount card. Without any discount, generic cash prices range from $30 to $80 depending on dose and pharmacy.
Does New Jersey Medicaid cover Vyvanse?
Yes. NJ FamilyCare covers Vyvanse with prior authorization. Your prescriber must typically document that a first-line stimulant was tried or is clinically inappropriate before Medicaid will approve coverage.
Is compounded lisdexamfetamine legal in New Jersey?
Yes. Licensed 503A compounding pharmacies in NJ can compound lisdexamfetamine with a valid patient-specific prescription. The pharmacy must hold both a NJ Board of Pharmacy license and DEA registration for Schedule II substances.
Can I get Vyvanse via telehealth in New Jersey?
Yes. New Jersey permits telehealth prescribing of Schedule II controlled substances including Vyvanse. The prescriber must conduct a live audio-video evaluation and hold a valid NJ medical license and CDS registration.
Which insurance plans cover Vyvanse in New Jersey?
Most commercial plans, ACA Marketplace plans, and NJ Medicaid cover lisdexamfetamine. Formulary tier and copay amounts vary. Medicare Part D does not mandate ADHD stimulant coverage, though some Medicare Advantage plans include it.
What's the cheapest way to get Vyvanse in New Jersey?
Fill generic lisdexamfetamine at a discount pharmacy like Costco or CostPlus Drugs with a coupon card. Prices can drop below $20 per month for some strengths. Compounded lisdexamfetamine from a 503A pharmacy may also cost less.
Are there New Jersey Vyvanse discount programs?
Yes. The Takeda Help at Hand Patient Assistance Program provides free brand Vyvanse to uninsured patients at or below 250% of the federal poverty level. Pharmacy discount cards like GoodRx and RxSaver also reduce generic prices at NJ pharmacies.
How does the Takeda savings card work in New Jersey?
Commercially insured NJ patients can use the Takeda Vyvanse savings card to reduce their copay to as low as $30 per fill. The card is not valid for patients on Medicaid, Medicare, or other government insurance. It is accepted at most NJ retail pharmacies.

References

  1. Takeda Pharmaceuticals. Vyvanse prescribing information and savings programs. https://www.vyvanse.com
  2. U.S. Food and Drug Administration. Vyvanse (lisdexamfetamine dimesylate) FDA-approved labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s045,208510s007lbl.pdf
  3. Wigal T, Brams M, Gasior M, et al. Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Atten Disord. 2017;21(12):997-1006. https://pubmed.ncbi.nlm.nih.gov/26861148/
  4. Wolraich ML, Hagan JF, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of ADHD in children and adolescents. Pediatrics. 2019;144(4):e20192528. https://pubmed.ncbi.nlm.nih.gov/31570648/
  5. U.S. Food and Drug Administration. Generic drug facts. Bioequivalence standards. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
  6. American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921. https://pubmed.ncbi.nlm.nih.gov/17581453/
  7. U.S. Food and Drug Administration. Human drug compounding: Section 503A. https://www.fda.gov/drugs/human-drug-compounding/section-503a-federal-food-drug-and-cosmetic-act
  8. IQVIA Institute for Human Data Science. National Prescription Audit, 2022 annual report. https://www.iqvia.com
  9. Dreyfus J, Patel M, Engel T, et al. Impact of manufacturer copay cards on medication adherence and health plan costs. J Manag Care Spec Pharm. 2021;27(6):768-779. https://pubmed.ncbi.nlm.nih.gov/34057007/
  10. New Jersey Legislature. Senate Bill 2559: Telehealth access and parity. Signed into law July 2020. https://www.njleg.state.nj.us
  11. U.S. Drug Enforcement Administration. Telemedicine prescribing of controlled substances: Final rule updates (2024). https://www.fda.gov/drugs